Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos

Translated title of the contribution: Codeletion of p15, p 16 and methylthioadenosine phosphorylase (MTAP) genes in human osteosarcoma

José M. García-Castellano, J. H. Healey, R. Gorlick

Research output: Contribution to journalArticle

Abstract

The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma and its codeletion with the tumor suppressor genes p15INK4b and p16INK4a. Osteosarcoma patient samples (n = 96) and three osteosarcoma cell lines were analyzed. DNA was analyzed for MTAP, p15INK4b and p16INK4a genes codeletions and expression was measured at the RNA and protein levels. Deletion of MTAP was found in 37.5 % of patient samples and in one of the three cell lines (HOS). It was always codeleted with the exon 1 of p15INK4b. In all cases in which an MTAP gene deletion was observed there was absence of detectable mRNA and protein. In four osteosarcoma patients, an MTAP deletion which was not evident at diagnosis was delected in subsequent tumor samples. In the osteosarcoma cell lines with homozygous deletion of MTAP (HOS) a 10-fold greater sensitivity to chemotherapeutic agents which act on de novo synthesis of purines was observed. The MTAP gene is commonly deleted in osteosarcoma patient samples leading to an absence of mRNA and protein expression. These results indicate that inhibitors of de novo purine synthesis or methionine depletion may be effective as treatment for osteosarcoma patients whose tumors fail to express MTAP.

Original languageSpanish
Pages (from-to)11-18
Number of pages8
JournalMapfre Medicina
Volume14
Issue number1
StatePublished - 2003
Externally publishedYes

Fingerprint

Osteosarcoma
Genes
Cell Line
p16 Genes
Purines
Messenger RNA
Proteins
5'-methylthioadenosine phosphorylase
Gene Deletion
Tumor Suppressor Genes
Methionine
Exons
Neoplasms
RNA
Gene Expression
DNA

Keywords

  • Deletion
  • INK4
  • Methylthioadenosine phosphorylase
  • Osteosarcoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

García-Castellano, J. M., Healey, J. H., & Gorlick, R. (2003). Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos. Mapfre Medicina, 14(1), 11-18.

Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos. / García-Castellano, José M.; Healey, J. H.; Gorlick, R.

In: Mapfre Medicina, Vol. 14, No. 1, 2003, p. 11-18.

Research output: Contribution to journalArticle

García-Castellano, JM, Healey, JH & Gorlick, R 2003, 'Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos', Mapfre Medicina, vol. 14, no. 1, pp. 11-18.
García-Castellano, José M. ; Healey, J. H. ; Gorlick, R. / Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos. In: Mapfre Medicina. 2003 ; Vol. 14, No. 1. pp. 11-18.
@article{4c3a47b2097947aabccbd78c74be24de,
title = "Estudio de codeleci{\'o}n de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos",
abstract = "The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma and its codeletion with the tumor suppressor genes p15INK4b and p16INK4a. Osteosarcoma patient samples (n = 96) and three osteosarcoma cell lines were analyzed. DNA was analyzed for MTAP, p15INK4b and p16INK4a genes codeletions and expression was measured at the RNA and protein levels. Deletion of MTAP was found in 37.5 {\%} of patient samples and in one of the three cell lines (HOS). It was always codeleted with the exon 1 of p15INK4b. In all cases in which an MTAP gene deletion was observed there was absence of detectable mRNA and protein. In four osteosarcoma patients, an MTAP deletion which was not evident at diagnosis was delected in subsequent tumor samples. In the osteosarcoma cell lines with homozygous deletion of MTAP (HOS) a 10-fold greater sensitivity to chemotherapeutic agents which act on de novo synthesis of purines was observed. The MTAP gene is commonly deleted in osteosarcoma patient samples leading to an absence of mRNA and protein expression. These results indicate that inhibitors of de novo purine synthesis or methionine depletion may be effective as treatment for osteosarcoma patients whose tumors fail to express MTAP.",
keywords = "Deletion, INK4, Methylthioadenosine phosphorylase, Osteosarcoma",
author = "Garc{\'i}a-Castellano, {Jos{\'e} M.} and Healey, {J. H.} and R. Gorlick",
year = "2003",
language = "Spanish",
volume = "14",
pages = "11--18",
journal = "Mapfre Medicina",
issn = "1130-5665",
publisher = "Fundacion Mapfre Medicina",
number = "1",

}

TY - JOUR

T1 - Estudio de codeleción de los genes del locus 9p21, p15, p16 y MTAP en osteosarcomas humanos

AU - García-Castellano, José M.

AU - Healey, J. H.

AU - Gorlick, R.

PY - 2003

Y1 - 2003

N2 - The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma and its codeletion with the tumor suppressor genes p15INK4b and p16INK4a. Osteosarcoma patient samples (n = 96) and three osteosarcoma cell lines were analyzed. DNA was analyzed for MTAP, p15INK4b and p16INK4a genes codeletions and expression was measured at the RNA and protein levels. Deletion of MTAP was found in 37.5 % of patient samples and in one of the three cell lines (HOS). It was always codeleted with the exon 1 of p15INK4b. In all cases in which an MTAP gene deletion was observed there was absence of detectable mRNA and protein. In four osteosarcoma patients, an MTAP deletion which was not evident at diagnosis was delected in subsequent tumor samples. In the osteosarcoma cell lines with homozygous deletion of MTAP (HOS) a 10-fold greater sensitivity to chemotherapeutic agents which act on de novo synthesis of purines was observed. The MTAP gene is commonly deleted in osteosarcoma patient samples leading to an absence of mRNA and protein expression. These results indicate that inhibitors of de novo purine synthesis or methionine depletion may be effective as treatment for osteosarcoma patients whose tumors fail to express MTAP.

AB - The aim of this study was to investigate the frequency of molecular alterations in MTAP in osteosarcoma and its codeletion with the tumor suppressor genes p15INK4b and p16INK4a. Osteosarcoma patient samples (n = 96) and three osteosarcoma cell lines were analyzed. DNA was analyzed for MTAP, p15INK4b and p16INK4a genes codeletions and expression was measured at the RNA and protein levels. Deletion of MTAP was found in 37.5 % of patient samples and in one of the three cell lines (HOS). It was always codeleted with the exon 1 of p15INK4b. In all cases in which an MTAP gene deletion was observed there was absence of detectable mRNA and protein. In four osteosarcoma patients, an MTAP deletion which was not evident at diagnosis was delected in subsequent tumor samples. In the osteosarcoma cell lines with homozygous deletion of MTAP (HOS) a 10-fold greater sensitivity to chemotherapeutic agents which act on de novo synthesis of purines was observed. The MTAP gene is commonly deleted in osteosarcoma patient samples leading to an absence of mRNA and protein expression. These results indicate that inhibitors of de novo purine synthesis or methionine depletion may be effective as treatment for osteosarcoma patients whose tumors fail to express MTAP.

KW - Deletion

KW - INK4

KW - Methylthioadenosine phosphorylase

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0037275924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037275924&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0037275924

VL - 14

SP - 11

EP - 18

JO - Mapfre Medicina

JF - Mapfre Medicina

SN - 1130-5665

IS - 1

ER -